Experts Debate Role of AI in Bridging Healthcare Inequality

As the use of artificial intelligence (AI) in healthcare expands, experts, including those from the World Health Organization (WHO), are voicing concerns about its implications. The WHO has issued comprehensive guidelines aimed at the ethical deployment of AI in health, simultaneously co-leading the Global Initiative on AI for Health (GI-AI4H). In these guidelines, the WHO stresses the importance of considering methodological aspects to ensure that AI contributes positively to scientific progress and supports universal health care.

Risks Associated with AI in Healthcare

Despite the potential advantages of AI, various risks warrant careful attention. One significant concern is the potential for diagnostic errors, where AI systems might misinterpret medical images or provide faulty treatment recommendations. Additionally, the algorithms that power AI often learn from historical data, which can be biased. This leads to concerns about inequality, particularly if the training data does not reflect diverse populations, resulting in subpar performance for underrepresented groups.

Data privacy is another critical issue. The integration of AI in healthcare often necessitates access to sensitive patient information, raising alarms about potential data breaches. Furthermore, the phenomenon known as automation bias can lead healthcare professionals to over-rely on AI recommendations, which may not always align with the ethical frameworks and operational values of healthcare providers. As AI becomes more embedded in healthcare systems, the potential for systemic risks also increases.

Potential Benefits of AI in Healthcare

While these risks are significant, some industry leaders argue that the problem lies not in AI itself, but in its application. Dr. Essam Hamza, CEO of Rocket Doctor AI Inc., contends that certain AI technologies can significantly benefit both healthcare professionals and patients. He asserts that AI can provide safer, evidence-based alternatives that help reduce errors, facilitate earlier disease detection, and create personalized treatment plans.

Dr. Hamza emphasizes that AI can streamline drug discovery, enhance imaging analysis, and improve administrative processes, ultimately leading to better patient outcomes and reduced costs. He acknowledges the WHO’s cautionary stance regarding the rapid adoption of AI in healthcare but advocates for a more transparent approach. “Too many systems rely on opaque algorithms and the possibility of hallucinations, without the legal or clinical safeguards patients and health workers deserve,” he stated in an interview with Digital Journal.

At Rocket Doctor AI, Dr. Hamza explains that the company’s technology is designed to counter the risks associated with less transparent AI systems. The proprietary Global Library of Medicine (GLM) and its suite of AI-driven solutions are built on a foundation of vetted medical knowledge, developed over more than a decade by hundreds of clinicians. “We use large language models only as a presentation layer — never as the source of clinical judgment,” he adds, reinforcing the importance of grounded clinical pathways and recommendations.

Dr. Hamza believes that AI should support healthcare professionals rather than replace them, enhancing safety and decision-making to ultimately deliver improved outcomes for patients. He insists that while innovation in healthcare must advance rapidly, it is equally crucial that it does so safely. “Our commitment is to do both,” he concludes.

The ongoing debate surrounding AI in healthcare highlights a crucial intersection of technology and ethics, as stakeholders from multiple sectors work to navigate the complexities of integrating AI into health systems worldwide. The discourse will likely continue as the healthcare landscape evolves, and the role of AI becomes increasingly pronounced.